Paladin Capital Management, Llc - Net Worth and Insider Trading
Paladin Capital Management, Llc Net Worth
The estimated net worth of Paladin Capital Management, Llc is at least $163 Million dollars as of 2024-04-18. Paladin Capital Management, Llc is the 10% Owner of 10x Genomics Inc and owns about 5,617,583 shares of 10x Genomics Inc (TXG) stock worth over $163 Million. Details can be seen in Paladin Capital Management, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paladin Capital Management, Llc has not made any transactions after 2020-04-30 and currently still holds the listed stock(s).
Transaction Summary of Paladin Capital Management, Llc
Paladin Capital Management, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paladin Capital Management, Llc owns 1 companies in total, including 10x Genomics Inc () .
Click here to see the complete history of Paladin Capital Management, Llc’s form 4 insider trades.
Insider Ownership Summary of Paladin Capital Management, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| 10x Genomics Inc | 2020-04-30 | 10 percent owner |
Paladin Capital Management, Llc Latest Holdings Summary
Paladin Capital Management, Llc currently owns a total of 1 stock. Paladin Capital Management, Llc owns 5,617,583 shares of 10x Genomics Inc (TXG) as of April 30, 2020, with a value of $163 Million.
Latest Holdings of Paladin Capital Management, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TXG | 10x Genomics Inc | 2020-04-30 | 5,617,583 | 28.95 | 162,629,028 |
Holding Weightings of Paladin Capital Management, Llc
Paladin Capital Management, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Paladin Capital Management, Llc has made a total of 1 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 10x Genomics Inc is the sale of 1,000,568 shares on April 30, 2020, which brought Paladin Capital Management, Llc around $78 Million.
Insider Trading History of Paladin Capital Management, Llc
- 1
Paladin Capital Management, Llc Trading Performance
Paladin Capital Management, Llc Ownership Network
Ownership Network List of Paladin Capital Management, Llc
Ownership Network Relation of Paladin Capital Management, Llc
Paladin Capital Management, Llc Owned Company Details
What does 10x Genomics Inc do?
Who are the key executives at 10x Genomics Inc?
Paladin Capital Management, Llc is the 10 percent owner of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .
10x Genomics Inc () Insider Trades Summary
Over the past 18 months, Paladin Capital Management, Llc made no insider transaction in 10x Genomics Inc (). Other recent insider transactions involving 10x Genomics Inc () include a net sale of 90,937 shares made by Serge Saxonov , a net sale of 36,912 shares made by Benjamin J. Hindson , and a net sale of 9,758 shares made by Justin J. Mcanear .
In summary, during the past 3 months, insiders sold 12,959 shares of 10x Genomics Inc () in total and bought 0 shares, with a net sale of 12,959 shares. During the past 18 months, 208,804 shares of 10x Genomics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,804 shares.
10x Genomics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
10x Genomics Inc Insider Transactions
Paladin Capital Management, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Paladin Capital Management, Llc. You might contact Paladin Capital Management, Llc via mailing address: 2020 K Street, Nw, Suite 620, Washington Dc 20006.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
